Clinical Trial Update: A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of rituximab in combination with methotrexate for moderate to severe rheumatoid arthritis; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2011-10-07